Patents by Inventor Elliott Bennett-Guerrero

Elliott Bennett-Guerrero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9713561
    Abstract: Exemplary embodiments are directed to a controller and/or a procedure table. The procedure table includes a driver that moves the table, and at least one indicator that indicates status of a condition of the table. The controller includes an unlock actuator that enables the driver to move the table, and a lock actuator that prevents the driver from moving the table while enabling the at least one indicator to continue indicating the status. In some exemplary embodiments, the unlock actuator does not enable the driver to move the table until after expiration of a specified delay period that begins upon actuation of the unlock actuator. Other exemplary embodiments also include a delay period indicator that indicates initiation of the delay period upon actuation of the unlock actuator, and that terminates the indication upon expiration of the delay period.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: July 25, 2017
    Assignee: SAFER CARE, L.L.C.
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20170071502
    Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Inventor: Elliott BENNETT-GUERRERO
  • Patent number: 9532739
    Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: January 3, 2017
    Assignee: GRAVITAS MEDICAL, INC.
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20150257654
    Abstract: Some embodiments are directed to an apparatus for monitoring patient orientation. A reusable sensor is configured to detect inclination angles of an anterior region of the patient. An elongated disposable attachment device is configured for removable attachment to both the sensor and the patient's anterior region such that the direction of elongation of the attachment device extends along the patient's sternum. The attachment device includes a sensor attachment portion configured for removable attachment to the sensor such that the sensor is prevented from direct contact with the patient, and a patient attachment portion configured for removable attachment to the patient's anterior region.
    Type: Application
    Filed: April 8, 2015
    Publication date: September 17, 2015
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20150224008
    Abstract: Exemplary embodiments are directed to a controller and/or a procedure table. The procedure table includes a driver that moves the table, and at least one indicator that indicates status of a condition of the table. The controller includes an unlock actuator that enables the driver to move the table, and a lock actuator that prevents the driver from moving the table while enabling the at least one indicator to continue indicating the status. In some exemplary embodiments, the unlock actuator does not enable the driver to move the table until after expiration of a specified delay period that begins upon actuation of the unlock actuator. Other exemplary embodiments also include a delay period indicator that indicates initiation of the delay period upon actuation of the unlock actuator, and that terminates the indication upon expiration of the delay period.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 13, 2015
    Inventor: Elliott Bennett-Guerrero
  • Patent number: 9089466
    Abstract: Exemplary embodiments are directed to a controller and/or a procedure table. The procedure table includes a driver that moves the table, and at least one indicator that indicates status of a condition of the table. The controller includes an unlock actuator that enables the driver to move the table, and a lock actuator that prevents the driver from moving the table while enabling the at least one indicator to continue indicating the status. In some exemplary embodiments, the unlock actuator does not enable the driver to move the table until after expiration of a specified delay period that begins upon actuation of the unlock actuator. Other exemplary embodiments also include a delay period indicator that indicates initiation of the delay period upon actuation of the unlock actuator, and that terminates the indication upon expiration of the delay period.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: July 28, 2015
    Assignee: Safer Care, LLC
    Inventor: Elliott Bennett-Guerrero
  • Patent number: 9028407
    Abstract: Some embodiments are directed to an apparatus for monitoring patient orientation. A reusable sensor is configured to detect inclination angles of an anterior region of the patient. An elongated disposable attachment device is configured for removable attachment to both the sensor and the patient's anterior region such that the direction of elongation of the attachment device extends along the patient's sternum. The attachment device includes a sensor attachment portion configured for removable attachment to the sensor such that the sensor is prevented from direct contact with the patient, and a patient attachment portion configured for removable attachment to the patient's anterior region.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: May 12, 2015
    Assignee: Safer Care LLC
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20130152307
    Abstract: Exemplary embodiments are directed to a controller and/or a procedure table. The procedure table includes a driver that moves the table, and at least one indicator that indicates status of a condition of the table. The controller includes an unlock actuator that enables the driver to move the table, and a lock actuator that prevents the driver from moving the table while enabling the at least one indicator to continue indicating the status. In some exemplary embodiments, the unlock actuator does not enable the driver to move the table until after expiration of a specified delay period that begins upon actuation of the unlock actuator. Other exemplary embodiments also include a delay period indicator that indicates initiation of the delay period upon actuation of the unlock actuator, and that terminates the indication upon expiration of the delay period.
    Type: Application
    Filed: December 20, 2011
    Publication date: June 20, 2013
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20120323091
    Abstract: Embodiments relate to guiding medical care based on detected gastric function. For example, gastric acid stimulant or suppressant is administered, and then a change in the gastric juice H+ concentration is measured. This change is compared to a guidance H+ concentration differential indicative of relatively healthy gastric function. Medical care is guided based on a relatively healthy gastric function if the measured H+ concentration differential is equal to or exceeds the guidance H+ concentration differential, while medical care is guided based on a relatively unhealthy gastric function if the measured H+ concentration differential is less than the guidance H+ concentration differential. Disclosed embodiments implementing this procedure include, but are not limited to, methods, apparatus, processors, computer programs, and computer-readable mediums.
    Type: Application
    Filed: June 13, 2012
    Publication date: December 20, 2012
    Inventor: Elliott Bennett-Guerrero
  • Publication number: 20040219587
    Abstract: Complete core LPS (lacking O-polysaccharide side chains) from Gram-negative bacteria are incorprated into a vaccine typically in liposomes. The complete core of E. coli K 12 is particularly useful. Upon administration to a mammal the vaccine stimulated synthesis of antibodies which are cross-protective against smooth and rough forms of LPS from at least two different Gram-negative bacterial strains having different core structures.
    Type: Application
    Filed: April 6, 2004
    Publication date: November 4, 2004
    Inventors: Elliott Bennett-Guerrero, George Robin Barclay, Ian Raymond Poxton, Thomas James McIntosh, David Scott Snyder
  • Patent number: 6749831
    Abstract: Compare core LPS (lacking O-polysaccharide side chains) from Gram-negative bacteria are incorporated into a vaccine typically in liposomes. The complete core of E. coli K 12 is particularly useful. Upon administration to a mammal the vaccine stimulates synthesis of antibodies which are cross-protective against smooth and rough forms of LPS from at least two different Gram-negative bacterial strains having different core structures.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: June 15, 2004
    Assignee: Medical Defense Technology, LLC
    Inventors: Elliott Bennett-Guerrero, George Robin Barclay, Ian Raymond Poxton, Thomas James McIntosh, David Scott Snyder
  • Patent number: 6365128
    Abstract: A method of guiding the care of a critically ill patient or other high risk patient, said method comprising administering an effective dose of a gastric acid stimulant or suppressant agent and then measuring for an acute change in the gastric juice pH. A patient who demonstrates a significant change in the gastric juice pH using this test can have their medical care normalized in an accelerated fashion thereby reducing the duration, intensity, and cost of their care. Conversely, a patient who is not responsive is not ready for reduced support and may require more support.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: April 2, 2002
    Assignee: Medical Defence Technologies, LLC
    Inventors: Elliott Bennett-Guerrero, Michael G. Mythen